BioLife Solutions Biopreservation Media Products Used at NeoStem Subsidiary Progenitor Cell Therapy
October 14, 2014
BOTHELL, WA — — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today provided an update on use of the Company’s HypoThermosol storage/shipping media and CryoStor cryopreservation freeze media [...]
Scientific Advisory Board Formed to Advance Genome Interpretation and Biomarker Discovery
October 14, 2014
SAN DIEGO –– Cypher Genomics, Inc., the genome informatics company, announced today the formation of a scientific advisory board (SAB) to guide the development and implementation of Cypher's products, which include MantisTM, the genome interpretation software as a service offering, and CoralTM, a biomarker discovery service. Drs. Kelly Bethel, Michael Hultner, Myla Lai-Goldman, Arnold (Arnie) [...]
October 14, 2014
Bielefeld -- LaVison BioTec, developers of advanced microscopy solutions for the life sciences, report on users of their Ultramicroscope Light Sheet Fluorescence Microscope system to aid the research of the Miami Project to Cure Paralysis under the supervision of Professor Vance Lemmon, the Walter G. Ross Distinguished Chair in Developmental Neuroscience & Professor of Neurological [...]
RANGATIRA INCREASES STAKE IN MAGRITEK
October 14, 2014
Wellington, New Zealand -- Magritek, world leading providers of benchtop NMR and MRI instruments, announced that New Zealand institutional investor, Rangatira Limited, has increased its stake in the company Last year Rangatira, the Wellington-based investment company, acquired a 12% stake in Magritek for an undisclosed sum. As part of that transaction, Rangatira entered into a [...]
October 14, 2014
Billerica, MA -– Seahorse Bioscience and the University of Alabama at Birmingham (UAB) announced today that they have entered into a partnership to study the bioenergetic health of cells in cryo-preserved blood – a step that will ultimately produce a first-of-its-kind clinical test of metabolic bioenergetic health. Because cutting-edge work is now being done on [...]
Improving the Consistency & Efficiency of Early Drug Discovery
October 14, 2014
A leading UK supplier of early-stage drug discovery and development process services has improved the consistency and efficiency of its assays using VIAFLO II pipettes and a VIAFLO ASSIST from INTEGRA. By mounting a VIAFLO II electronic pipette on the VIAFLO ASSIST, the pipette’s protocols can be carried out fully automatically. A senior scientist at [...]
Genomics England publishes results of its annotation assessment
October 14, 2014
Genomics England, the company leading the UK’s 100,000 Genomes Project, has released details of those companies that distinguished themselves in its annotation assessment exercise. Genomics England is committed to kick-starting the development of a UK genomics industry and this assessment exercise is part of that aim, as well as to evaluate and select potential service [...]
SomaLogic announces agreement to deploy SOMAscan assay at NIH Center
October 13, 2014
SomaLogic, Inc., announced today that the National Institutes of Health (NIH) Center for Human Immunology, Autoimmunity and Inflammation (CHI) will use the SOMAscan™ proteomics assay for research with collaborators across the NIH. It is expected that the SOMAscan assay will be installed and fully functional at CHI by the beginning of 2015, under the leadership [...]
SomaLogic announces agreement to deploy SOMAscan assay at NIH Center
October 13, 2014
SomaLogic, Inc., announced today that the National Institutes of Health (NIH) Center for Human Immunology, Autoimmunity and Inflammation (CHI) will use the SOMAscan™ proteomics assay for research with collaborators across the NIH. It is expected that the SOMAscan assay will be installed and fully functional at CHI by the beginning of 2015, under the leadership [...]
Genomics England names QIAGEN Bioinformatics one of the UK100K project assessment winners
October 13, 2014
Redwood City, Calif. -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced today that its business area, QIAGEN Bioinformatics, has been named by Genomics England (GeL) an assessment winner for the UK100K project, along with other life science technology providers. The company will be providing project researchers access to Ingenuity® Variant Analysis™, a powerful [...]

